ADAMTS-13 Behavior in Thrombocytopenia of Infectious Origin in ICU Patients. [PDF]
Gontla VDK +5 more
europepmc +1 more source
The impact of the COVID-19 pandemic on incidence and clinical presentation of thrombotic microangiopathies: data from a laboratory centralizing ADAMTS-13 testing in Quebec. [PDF]
Merlen C +8 more
europepmc +1 more source
ADAMTS 13 deficiency is associated with abnormal distribution of von Willebrand factor multimers in patients with COVID-19. [PDF]
Pascreau T +5 more
europepmc +1 more source
Secretion of von Willebrand Factor and Suppression of ADAMTS-13 Activity by Markedly High Concentration of Ferritin. [PDF]
Bashir DA +12 more
europepmc +1 more source
A chronic recurrent course of moschcowitz disease
I I Kalinina +5 more
doaj
A mutant complement factor H (W1183R) enhances proteolytic cleavage of von Willebrand factor by ADAMTS-13 under shear. [PDF]
Cao W, Liu Y, Zhang XF, Zheng XL.
europepmc +1 more source
Thrombotic thrombocytopenic purpura (TTP) response following COVID-19 infection: Implications for the ADAMTS-13-von Willebrand factor axis. [PDF]
Maharaj S, Xue R, Rojan A.
europepmc +1 more source
Assessment of ferritin and hepcidin levels in splenectomised and non-splenectomised β-thalassemia major patients and exploring a potential correlation with von Willebrand factor and ADAMTS-13. [PDF]
Al-Awadhi A +3 more
europepmc +1 more source
Hemophagocytic lymphohistiocytosis is associated with deficiency and closed conformation of ADAMTS-13. [PDF]
Launois A +8 more
europepmc +1 more source
ADAMTS-13: A Prognostic Biomarker for Portal Vein Thrombosis in Japanese Patients with Liver Cirrhosis. [PDF]
Suzuki J +25 more
europepmc +1 more source

